32075117|t|Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism.
32075117|a|We investigated the influence of cannabidiol (CBD) on blood pressure (BP) and heart rate (HR) in spontaneously (SHR) and deoxycorticosterone (DOCA-salt) hypertensive rats. Hypertension was connected with increases in cardiac and plasma markers of lipid peroxidation in both models, whereas cardiac endocannabinoid levels decreased in SHR and increased in DOCA-salt. CBD (10 mg/kg once a day for 2 weeks) did not modify BP and HR in hypertension but counteracted pro-oxidant effects. Moreover, it decreased cardiac or plasma levels of anandamide, 2-arachidonoylglycerol and oleoyl ethanolamide in DOCA-salt and inhibited the activity of fatty acid amide hydrolase (FAAH) in both models. In the respective normotensive control rats, CBD increased lipid peroxidation, free fatty acid levels and FAAH activity. In conclusion, chronic CBD administration does not possess antihypertensive activity in a model of primary and secondary (DOCA-salt) hypertension, despite its antioxidant effect. The latter may be direct rather than based on the endocannabinoid system. The unexpected CBD-related increase in lipid peroxidation in normotensive controls may lead to untoward effects; thus, caution should be kept if CBD is used therapeutically.
32075117	8	19	Cannabidiol	Chemical	MESH:D002185
32075117	71	75	Rats	Species	10116
32075117	103	115	Hypertension	Disease	MESH:D006973
32075117	158	173	Endocannabinoid	Chemical	MESH:D063388
32075117	203	208	Lipid	Chemical	MESH:D008055
32075117	254	265	cannabidiol	Chemical	MESH:D002185
32075117	267	270	CBD	Chemical	MESH:D002185
32075117	342	361	deoxycorticosterone	Chemical	MESH:D003900
32075117	363	372	DOCA-salt	Chemical	-
32075117	374	386	hypertensive	Disease	MESH:D006973
32075117	387	391	rats	Species	10116
32075117	393	405	Hypertension	Disease	MESH:D006973
32075117	468	473	lipid	Chemical	MESH:D008055
32075117	519	534	endocannabinoid	Chemical	MESH:D063388
32075117	576	585	DOCA-salt	Chemical	-
32075117	587	590	CBD	Chemical	MESH:D002185
32075117	653	665	hypertension	Disease	MESH:D006973
32075117	755	765	anandamide	Chemical	MESH:C078814
32075117	767	789	2-arachidonoylglycerol	Chemical	MESH:C094503
32075117	794	813	oleoyl ethanolamide	Chemical	MESH:C488250
32075117	817	826	DOCA-salt	Chemical	-
32075117	857	883	fatty acid amide hydrolase	Gene	29347
32075117	885	889	FAAH	Gene	29347
32075117	946	950	rats	Species	10116
32075117	952	955	CBD	Chemical	MESH:D002185
32075117	966	971	lipid	Chemical	MESH:D008055
32075117	986	1001	free fatty acid	Chemical	MESH:D005230
32075117	1013	1017	FAAH	Gene	29347
32075117	1051	1054	CBD	Chemical	MESH:D002185
32075117	1150	1159	DOCA-salt	Chemical	-
32075117	1161	1173	hypertension	Disease	MESH:D006973
32075117	1257	1272	endocannabinoid	Chemical	MESH:D063388
32075117	1296	1299	CBD	Chemical	MESH:D002185
32075117	1320	1325	lipid	Chemical	MESH:D008055
32075117	1426	1429	CBD	Chemical	MESH:D002185
32075117	Positive_Correlation	MESH:D002185	MESH:D008055
32075117	Association	MESH:D002185	MESH:D063388
32075117	Positive_Correlation	MESH:D003900	MESH:D006973
32075117	Negative_Correlation	MESH:C078814	MESH:D002185
32075117	Negative_Correlation	MESH:C094503	MESH:D002185
32075117	Negative_Correlation	MESH:D002185	29347
32075117	Negative_Correlation	MESH:C488250	MESH:D002185
32075117	Association	MESH:D008055	MESH:D006973
32075117	Positive_Correlation	MESH:D002185	MESH:D005230

